eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 08/05/2009
SPC Dioralyte Relief Raspberry and Blackcurrant


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Dioralyte Relief Raspberry

Dioralyte Relief Blackcurrant


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active ingredients per sachet:

Pre-cooked Rice Powder

6g

Sodium Citrate PhEur

580mg

Sodium Chloride PhEur

350mg

Potassium Chloride PhEur

300mg


Go to top of the page
3. PHARMACEUTICAL FORM

Sachet containing powder for mixing with water prior to administration.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the treatment of fluid and electrolyte loss associated with acute diarrhoea.


Go to top of the page
4.2 Posology and method of administration

Posology

Adults and children:

One sachet after every loose motion up to a maximum of 5 sachets per day for 3-4 days.

Infants from 3 months to one year under medical advice:

In the event of diarrhoea and depending on the extent of dehydration (loss of weight assessed at less than 10%) 150 to 200 ml/kg/24 hours of preparation may be given.

•   half the volume is to be given during the first 8 hours, and the other half during the next 16 hours.

•   in the event of vomiting accompanying the diarrhoea, the amount administered can be divided up (5 to 10 ml every 5 minutes) and this may be gradually increased until the infant can drink normally.

Method of Administration

Pour the contents of one sachet into a large glass. Add 200ml of drinking water. Mix well until the liquid has a milky appearance and drink the whole glassful Ensure that no solid is remaining at the bottom of the glass and do not use extra water to rinse out the glass. For infants and where drinking water is not available, the water should be freshly boiled and cooled. The solution should be made up immediately before use.


Go to top of the page
4.3 Contraindications

Dioralyte Relief should not be used in patients with phenylketonuria. However, there may be a number of conditions where treatment with Dioralyte Relief may be inappropriate, e.g. intestinal obstruction requiring surgical intervention, cases of severe renal or hepatic impairment.


Go to top of the page
4.4 Special warnings and precautions for use

For oral administration only. Dioralyte Relief should not be reconstituted in diluents other than water.

Each sachet should always be dissolved in 200ml water.

Dioralyte Relief should not be administered to infants under 3 months and for those aged 3 months to 1 year, administered under medical advice.

Infants under the age of 2 with diarrhoea should be seen by the physician as soon as possible.

If diarrhoea persists unremittingly for longer than 36 hours the patient should be reassessed by the physician.

No specific precautions are necessary in the elderly. However, care should be taken when administering Dioralyte Relief solution in cases of severe renal or hepatic impairment or other conditions where normal electrolyte balance may be disturbed. Dioralyte Rlief should not be used for self-treatment by patients on low potassium or sodium diets. The use of Dioralyte Relief in patients with these conditions should be supervised by a physician.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

Dioralyte Relief is not contraindicated in pregnancy or lactation but should be used on medical advice.


Go to top of the page
4.7 Effects on ability to drive and use machines

Dioralyte Relief could not be expected to affect the ability to drive or use machines.


Go to top of the page
4.8 Undesirable effects

None known.


Go to top of the page
4.9 Overdose

In the event of significant overdose, serum electrolytes should be evaluated as soon as possible, appropriate steps taken to correct any abnormalities and levels monitored until return to normal levels is established. This is particularly important in the very young.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Dioralyte Relief contains a balanced amount of electrolytes, starch and proteins in water. Oral rehydration therapy with Dioralyte Relief enables a dehydrated subject to be rehydrated rapidly. The presence of pre-cooked rice in the formulation enables watery stools to return to normal more rapidly.

The advantages of Dioralyte Relief are bound with its composition.

Water: the appropriate amount is essential to correct dehydration.

Starch: low osmotic capacity (unlike pure glucose) thus preventing any additional loss of fluid through the stools. Rice starch contains 20% amylose and 80% amylopectin.

Proteins: specific nutritional properties.

Electrolytes: essential for restoring the ionic equilibrium. The role of citrate is to correct the acidosis that occurs as a result of diarrhoea. Citrate also enhances the absorption of Na+ and is more stable than bicarbonate.


Go to top of the page
5.2 Pharmacokinetic properties

Content of electrolytes in the reconstituted preparation:

Na+

60 mmol/l

Cl-

50 mmol/l

K+

20 mmol/l

Citrate

10 mmol/l (or 30 meq/l)

Osmolarity

140 mosm/l


Go to top of the page
5.3 Preclinical safety data

Not applicable.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Dioralyte Relief Raspberry: Raspberry Flavour Givaudan 611417E, hypromellose, aspartame, ethanol 96%, purified water

Dioralyte Relief Blackcurrant: Blackcurrant Flavour Firmenich 501017, hypromellose, aspartame, ethanol 96%, purified water


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

A shelf life of 36 months is given for unopened sachets of the product when stored under the conditions given in section 6.4. Once reconstituted, any solution should be used within one hour, or within 24 hours if stored in a refrigerator.


Go to top of the page
6.4 Special precautions for storage

Store in a dry place under 25oC.


Go to top of the page
6.5 Nature and contents of container

Carton containing paper/PVDC sachets of Dioralyte Relief Raspberry or Blackcurrant powder. Dioralyte Relief Raspberry or Blackcurrant is available in packs of 6 sachets.


Go to top of the page
6.6 Special precautions for disposal and other handling

See section 4.2 for instructions on reconstitution.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Sanofi-aventis

One Onslow Street

Guildford

Surrey

GU1 4YS

UK


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

Dioralyte Relief Raspberry: PL 04425/0280

Dioralyte Relief Blackcurant: PL 04425/0273


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

Dioralyte Relief Raspberry: 19 March 2009

Dioralyte Relief Blackcurant: 9 February 2009


Go to top of the page
10. DATE OF REVISION OF THE TEXT

19 March 2009


Go to top of the page
11 LEGAL CLASSIFICATION

GSL



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/3562/SPC/


Active Ingredients/Generics

 
   potassium chloride
   sodium chloride
   sodium citrate
   rice powder